Stockreport

Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences

Sensei Biotherapeutics, Inc.  (SNSE) 
PDF BOSTON, March 06, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and developme [Read more]